Natural HDAC-1/8 inhibitor baicalein exerts therapeutic effect in CBF-AML

Yu, XX; Li, H; Hu, P; Qing, YJ; Wang, XY; Zhu, MY; Wang, HZ; Wang, ZY; Xu, JY; Guo, QL; Hui, H

Guo, QL; Hui, H (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Jiangsu Key Lab Carcinogenesis & Intervent,Jiangs, Key Lab Drug Qual Control & Pharmacovigilance,Min, Nanjing 211198, Jiangsu, Peoples R China.

CLINICAL AND TRANSLATIONAL MEDICINE, 2020; 10 (4):

Abstract

Background Although targeting histone deacetylases (HDACs) may be an effective strategy for core binding factor-acute myeloid leukemia (CBF-AML) harbo......

Full Text Link